ACE and cancer: One of the first studies that assessed the risk of cancer in hypertensive patients who received ACE inhibitors over a 15-year period, showed that the relative risk of incident and fatal cancer among 1559 patients receiving ACE inhibitors was significantly reduced in comparison with control subjects, most markedly for female-specific cancers [124].